MedTrace Logo

Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

NCT05958368 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2025-07-31

No results posted yet for this study

Summary

The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.

Conditions

  • Diabetes Mellitus, Type 2
  • Insulin
  • Fructosamine
  • C-Reactive Protein
  • Glucose
  • Overweight and Obesity

Interventions

OTHER

Avocado

The Hass Avocado group will consume 7 avocados a week (1 / day; \~240 kcals/d).

OTHER

Other Fruit(s)

The other fruits group will consume fruit(s) matched to the avocado in energy and form (i.e., solid fruit).

Sponsors & Collaborators

  • Prachi Singh

    collaborator UNKNOWN

  • Frank L. Greenway

    collaborator UNKNOWN

  • Robbie A. Beyl

    collaborator UNKNOWN

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • John W Apolzan, PhD · Pennington Biomedical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-10
Primary Completion
2026-05-30
Completion
2026-12-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05958368 on ClinicalTrials.gov